Skip to main content
. 2025 Jul 28;14(7):1602–1615. doi: 10.21037/tp-2025-409

Table 2. Baseline data of patients.

Study Sample size Male (%) Female (%) Age (years), mean [range] Disease type Mean course (years) Treatment (%)
Leshno A et al. (1) 150 70 30 8.72 [5–12] Vision problems 3.5 Myopia control (85%)
Lee Y et al. (2) 200 65 35 10.43 [7–14] Myopia 4.2 Digital intervention (90%)
Holton V et al. (3) 180 60.56 39.44 9.87 [6–12] Myopia/astigmatism 3 Matching lenses (80%)
Beryozkin A et al. (4) 100 55 45 8.15 [6–10] Retinal diseases 4 Clinical observation (60%)
Georgiou M et al. (5) 120 68.33 31.67 11.22 [9–15] High myopia 5.1 Laser treatment (75%)
Ortiz-Peregrina S et al. (6) 250 62 38 10.09 [7–13] Myopia control 3.8 Matching lenses (70%)
Lin W et al. (7) 130 72.31 27.69 9.54 [8–14] Short-sightedness 3 Laser treatment (80%)
Chang LC et al. (8) 180 66.67 33.33 11 [8–15] Myopia control 4.5 Eye drops (82%)
Yang A et al. (9) 140 69.29 30.71 10.35 [7–12] Myopia/hyperopia 4.3 Eye drops (85%)
Li W et al. (10) 160 63.75 36.25 9.87 [7–14] High myopia 3.6 Matching lenses (78%)
Liu YL et al. (11) 200 60 40 10.05 [6–13] Short-sightedness 4 Matching lenses (76%)
Wang J et al. (12) 220 64.55 35.45 9.8 [7–14] Myopia control 3.9 Laser treatment (79%)